Abstract

Despite advances in pharmaceutical treatment in recent years, a relatively high proportion of patients with asthma do not have adequate asthma control, causing chronic disability, poor quality of life, and multiple emergency department visits and hospitalizations. A multifaceted approach is needed to overcome the problems with managing asthma, and clinical inertia (CI) is a crucial concept to assist with this approach. It divides clinical inertia into three main categories, which include healthcare provider-related, patient-related, and healthcare system-related CI. The strategies to overcome these CI are complex, and the M-GAP approach, which combines a multidisciplinary approach, dissemination of guidelines, utilization of applications, and development and promotion of low-cost prescriptions, will help clinicians.

Details

Title
Clinical inertia in asthma
Author
Fukuda, Yosuke 1   VIAFID ORCID Logo  ; Homma, Tetsuya 2 ; Sagara, Hironori 2 

1  Yamanashi Red Cross Hospital, Department of Medicine, Division of Respiratory Medicine, Fujikawaguchiko-machi, Japan; Showa University School of Medicine, Department of Medicine, Division of Respiratory Medicine and Allergology, Shinagawa-ku, Japan (GRID:grid.410714.7) (ISNI:0000 0000 8864 3422) 
2  Showa University School of Medicine, Department of Medicine, Division of Respiratory Medicine and Allergology, Shinagawa-ku, Japan (GRID:grid.410714.7) (ISNI:0000 0000 8864 3422) 
Pages
34
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20551010
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1038/s41533-023-00356-5
ProQuest document ID
2877037530
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.